--- title: "Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy | THAR Stock News" description: "Tharimmune, Inc. will rebrand as Canton Strategic Holdings, Inc. effective February 18, 2026, with a new NASDAQ ticker symbol \"CNTN.\" The company aims to support institutional adoption of the Canton N" type: "news" locale: "en" url: "https://longbridge.com/en/news/276121924.md" published_at: "2026-02-17T04:10:00.000Z" --- # Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy | THAR Stock News > Tharimmune, Inc. will rebrand as Canton Strategic Holdings, Inc. effective February 18, 2026, with a new NASDAQ ticker symbol "CNTN." The company aims to support institutional adoption of the Canton Network's privacy-enabled public blockchain, processing $9 trillion in monthly transactions. Recent milestones include approval as a Super Validator and a $55 million capital raise. The rebranding aligns with its digital asset treasury strategy, enhancing shareholder value and institutional engagement in capital markets. *New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026* *Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction Volume* , /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) (the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the launch of a corporate rebrand in alignment with its digital asset treasury strategy. Effective Wednesday, February 18, 2026, the Company will change its name to Canton Strategic Holdings, Inc. In connection with the name change, the common stock of the Company will begin trading on NASDAQ under the ticker symbol "CNTN" prior to market open on February 18, 2026. Established in November 2025 through a $545 million private placement, the Company executes a differentiated digital asset treasury strategy that seeks to drive value through initiatives including Canton Coin acquisition, operation of a Super Validator, and continued investment in applications that accelerate institutional utility and adoption of the Canton Network across capital markets. Canton Strategic Holdings remains the first and only publicly traded company supported by the Canton Foundation. "Since launching our digital asset treasury strategy, we have continued to execute against a clear mandate to support institutional adoption of the Canton Network," said Mark Wendland, Chairman and CEO of the Company. "Our approval to operate a Super Validator on the Network, the expansion of institutional leadership on our Board of Directors, and our commitment to develop quarterly ecosystem reporting demonstrates our ability to strengthen the Canton ecosystem while delivering sustained value for shareholders." Significant recent milestones for the Company include: - Securing approval as a Super Validator, aligned with a commitment to provide ecosystem reports on a quarterly basis. - Deepening institutional expertise on the Board of Directors, including recent appointments of Former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley. - Closing of a $55 million underwritten registered offering to provide the Company with additional growth capital for the continued expansion and development of its Canton-centric digital asset treasury strategy. "From DTCC securing SEC consent for a pilot to tokenize U.S. Treasury securities, to global enterprises implementing onchain payroll, the utility of the Canton Network and its configurable privacy has quickly become the foundation for onchain financial rails," continued Mr. Wendland. "We are well-positioned to accelerate this modernization through our support of the Canton Network and strategic work to strengthen the ecosystem while driving value for shareholders." No action is required from stockholders in connection with the change of the Company's corporate name or ticker symbol. **About the Company** The Company (NASDAQ: THAR), is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company also operates clinical-stage biotech research and development. For more information, visit: www.cantonstrategic.com **Cautionary Note Regarding Forward-Looking Statements** This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law. Canton is a registered trademark of Digital Asset (Switzerland) GmbH. Digital Asset is not affiliated with, and has not sponsored or endorsed, the operations of Canton Strategic Holdings, Inc. **Contacts** Media: Gasthalter & Co. (212) 257-4170 canton@gasthalter.com Investors: ir@cantonstrategic.com **X:** @CantonStrategic **LinkedIn:** Linkedin.com/CantonStrategicHoldings **Website:** www.cantonstrategic.com SOURCE Tharimmune, Inc. ### Related Stocks - [THAR.US - Tharimmune](https://longbridge.com/en/quote/THAR.US.md) - [CNTN.US - Canton Strategic](https://longbridge.com/en/quote/CNTN.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Tharimmune 因董事会独立性问题面临纳斯达克的合规性挑战 | Tharimmune Inc. 收到了纳斯达克关于不符合上市规则 5605 的通知，原因是由于最近的辞职导致其董事会独立董事不足。纳斯达克已提供至 2026 年 11 月 6 日的补救期，以便公司恢复合规。Tharimmune 计划于 20 | [Link](https://longbridge.com/en/news/272746358.md) | | Tharimmune Inc.为首席运营官 Angela Dominy Radkowski 提交了初始实益拥有权声明 | Tharimmune Inc. 已向美国证券交易委员会（SEC）提交了初步的实益拥有权声明（Form 3），并指定 Angela Dominy Radkowski 为实益拥有者，担任首席运营官一职。该文件可以通过提供的链接访问。此新闻简报由 | [Link](https://longbridge.com/en/news/275667782.md) | | Tharimmune Inc.为董事 Jill E. Sommers 提交了初始实益持股声明 | Tharimmune Inc. 已向美国证券交易委员会提交了初步的受益所有权声明（表格 3），并列出了 Jill E. Sommers 为董事。完整的文件可以通过提供的链接访问。此新闻简报由 Public Technologies 生成，仅 | [Link](https://longbridge.com/en/news/275667458.md) | | Tharimmune 在任命新任主席和首席运营官后股价上涨 | 药物开发公司 Tharimmune 的股票在盘前交易中上涨 7.9%，至 4.24 美元。公司表示首席执行官 Mark Wendland 将担任董事长，接替 Vincent LoPriore，后者仍将留在董事会。公司还表示聘请 Angela | [Link](https://longbridge.com/en/news/275132618.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.